The rise of the 'science journalist' isn't about better reporting; it's a symptom of academic funding collapse and media desperation. Analyze the shift.
The narrative of 'science accelerated' masks a dangerous consolidation of power. Unpacking the true winners and losers in today's breakneck scientific progress.
The latest breakthroughs in aging science aren't about living forever—they're about extending the profitable middle years. Unpacking the hidden economics of longevity.
The world's oldest lab experiment isn't about physics; it's about institutional inertia. Discover who truly profits from this slow science.
The perpetual delay of the Gene Technology Bill isn't just bureaucratic incompetence; it's a strategic political retreat from innovation and massive economic opportunity.
The next wave of biotech isn't about gene editing; it's about data infrastructure. Discover the hidden winners in the coming 2026 technology shift.
The push for culture-centric science communication isn't about inclusion; it's a sophisticated rebranding effort that might solidify existing power structures in STEM.
The Donald Danforth Center's move into Rwandan crop biotechnology isn't just about feeding Africa; it’s about global seed control and the future of American agricultural dominance.
Behind the glossy veneer of 'translating science' in Cystic Fibrosis, we dissect the hidden economic winners and the ethical cost of next-gen therapies.
Forget personalized medicine. The 'health and wellness' breakthroughs of 2025 reveal a hidden agenda: monetizing anxiety. We dissect the real winners.
Beyond the headlines of new fungal compounds and golden sharks, the real story in 'this week in science' is about biotech hype vs. clinical reality.
Forget the interstellar news. The real story in science this year is the obsession with the 'tiny T. rex,' revealing deeper institutional decay.